semaglutide alzheimer's trial GLP-1 Drug Fails to Quell in Novo Nordisk Trials Novo Nordisk justifies reasoning behind
Description
Diabetes drug Ozempic can now be sold on the Russian market without the consent of the Danish pharmaceutical company.
JAMA Study comparing Semaglutide and Tirzepatide for Weight Loss Efficacy A recent study in JAMA Internal Medicine reveals that Tirzepatide may be more effective than Semaglutide in achieving significant weight loss for adults with overweight or obesity
Maybe it's time we rethought our own judgement around obesity treatment
Hint: it's a life rich in connection, nutrition, and strength.
